Pfizer invests in, licenses four clinical-stage assets to SpringWorks
Pfizer Inc. has created SpringWorks Therapeutics and licensed the start-up four of its rare disease programs.
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
- Reverse Licensing
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.